| Susan Guida Lcsw Pc | |
|
43 Dogwood Rd Albertson NY 11507-1003 | |
| (516) 621-2854 | |
| (516) 621-2854 |
| Full Name | Susan Guida Lcsw Pc |
|---|---|
| Speciality | Clinic/Center |
| Location | 43 Dogwood Rd, Albertson, New York |
| Authorized Official Name and Position | Susan Guida (PRESIDENT) |
| Authorized Official Contact | 5166212854 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Susan Guida Lcsw Pc 43 Dogwood Rd Albertson NY 11507-1003 Ph: (516) 621-2854 | Susan Guida Lcsw Pc 43 Dogwood Rd Albertson NY 11507-1003 Ph: (516) 621-2854 |
| NPI Number | 1093045932 |
|---|---|
| Provider Enumeration Date | 12/27/2009 |
| Last Update Date | 12/27/2009 |
| Medicare PECOS PAC ID | 5193856367 |
|---|---|
| Medicare Enrollment ID | O20100702000059 |
News Archive
In response to recent mass shootings and consistent public outcry, President Donald Trump's administration is considering a controversial proposal to monitor people with mental illness in hopes of preventing mass shootings.
Every year in the United States, about 800,000 people experience a stroke. Many are left with neurological complications such as paralysis on one side of the body, speech and language problems, vision issues, behavioral changes, and memory loss.
For quite some time, the "Holy Grail" in medical imaging has been the development of an effective method to image cell death as a means to intervene early in diseases and rapidly determine the effectiveness of treatments. A new paper by researchers at the University of Notre Dame and the Washington University School of Medicine describes important progress in using a synthetic probe to target dead and dying cells in mammary and prostate tumors in living animals.
For more than a decade, there have been no new therapies that have improved survival rates for patients with advanced melanoma. Today, at the 6th International Melanoma Congress for the Society for Melanoma Research, the Melanoma Research Foundation (MRF) announced a novel collaboration between the research community and pharmaceutical companies that will pool knowledge and resources to generate new breakthroughs in treatment.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093045932 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | 069724-1 (New York) | Primary |
| Provider Name | Susan J Guida |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1366682411 PECOS PAC ID: 0648302885 Enrollment ID: I20100723000000 |
News Archive
In response to recent mass shootings and consistent public outcry, President Donald Trump's administration is considering a controversial proposal to monitor people with mental illness in hopes of preventing mass shootings.
Every year in the United States, about 800,000 people experience a stroke. Many are left with neurological complications such as paralysis on one side of the body, speech and language problems, vision issues, behavioral changes, and memory loss.
For quite some time, the "Holy Grail" in medical imaging has been the development of an effective method to image cell death as a means to intervene early in diseases and rapidly determine the effectiveness of treatments. A new paper by researchers at the University of Notre Dame and the Washington University School of Medicine describes important progress in using a synthetic probe to target dead and dying cells in mammary and prostate tumors in living animals.
For more than a decade, there have been no new therapies that have improved survival rates for patients with advanced melanoma. Today, at the 6th International Melanoma Congress for the Society for Melanoma Research, the Melanoma Research Foundation (MRF) announced a novel collaboration between the research community and pharmaceutical companies that will pool knowledge and resources to generate new breakthroughs in treatment.
› Verified 1 days ago
News Archive
In response to recent mass shootings and consistent public outcry, President Donald Trump's administration is considering a controversial proposal to monitor people with mental illness in hopes of preventing mass shootings.
Every year in the United States, about 800,000 people experience a stroke. Many are left with neurological complications such as paralysis on one side of the body, speech and language problems, vision issues, behavioral changes, and memory loss.
For quite some time, the "Holy Grail" in medical imaging has been the development of an effective method to image cell death as a means to intervene early in diseases and rapidly determine the effectiveness of treatments. A new paper by researchers at the University of Notre Dame and the Washington University School of Medicine describes important progress in using a synthetic probe to target dead and dying cells in mammary and prostate tumors in living animals.
For more than a decade, there have been no new therapies that have improved survival rates for patients with advanced melanoma. Today, at the 6th International Melanoma Congress for the Society for Melanoma Research, the Melanoma Research Foundation (MRF) announced a novel collaboration between the research community and pharmaceutical companies that will pool knowledge and resources to generate new breakthroughs in treatment.
› Verified 1 days ago
Dr Ami Shah Psychology Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 68 Birch Hl, Albertson, NY 11507 Phone: 201-247-2663 |